Palatin Technologies Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PALATIN TECHNOLOGIES, and what generic alternatives to PALATIN TECHNOLOGIES drugs are available?
PALATIN TECHNOLOGIES has one approved drug.
There are five US patents protecting PALATIN TECHNOLOGIES drugs.
There are seventy-six patent family members on PALATIN TECHNOLOGIES drugs in twenty-six countries.
Summary for Palatin Technologies
International Patents: | 76 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Palatin Technologies
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | 6,794,489 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | 9,352,013 | ⤷ Sign Up | ⤷ Sign Up | ||||
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | 9,700,592 | ⤷ Sign Up | ⤷ Sign Up | ||||
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | 10,286,034 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Palatin Technologies
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Palatin Technologies | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | 6,579,968 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Palatin Technologies Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1196184 | ⤷ Sign Up |
South Korea | 20070036079 | ⤷ Sign Up |
Eurasian Patent Organization | 201590760 | ⤷ Sign Up |
Japan | 2008505917 | ⤷ Sign Up |
Canada | 2890081 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.